Stases are associated with blood–brain barrier damage and a restricted activation of coagulation in SHRSP


      Cerebral small vessel disease (CSVD) is a chronically proceeding pathology of small brain vessels associated with white matter lesions, lacunar infarcts, brain atrophy and microbleeds. CSVD leads to slowly increasing cognitive and functional deficits but may also cause stroke-like symptoms, if vessels in critical brain areas are affected. Spontaneously hypertensive stroke-prone rats (SHRSP) exhibit several vascular risk factors, develop infarcts and hemorrhages and therefore represent a relevant model for the study of CSVD. Using this animal model, we recently demonstrated that intravasal accumulations of erythrocytes, we interpreted as stases, stand at the beginning of a pathological vascular cascade. After stases microbleeds occur, which are followed by reactive microthromboses. Bleeds and thromboses finally cause hemorrhagic infarcts. Immunohistochemical stainings show, that plasma proteins like IgG are deposited in the walls of vessels affected by stases. Further, we found small clots and thread-shaped aggregations of thrombocytes as well as thread-shaped structures of von Willebrand-Factor within stases. Thus, we conclude that blood–brain barrier damages occur in the neighborhood of stases and stases seem to be associated with a restricted activation of blood coagulation without formation of obstructive thromboses. Finally, we demonstrate that small vessel damage rarely appears in the cerebellum. Even animals with multiple cerebral infarcts may be free of any cerebellar vascular pathology.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Amarenco P.
        • Bogousslavsky J.
        • Caplan L.R.
        • Donnan G.A.
        • Hennerici M.G.
        Classification of stroke subtypes.
        Cerebrovasc Dis. 2009; 27: 493-501
        • Aguero-Torres H.
        • Kivipelto M.
        • von Strauss E.
        Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia? A study from the kungsholmen project.
        Dement Geriatr Cogn Disord. 2006; 22: 244-249
        • Patel B.
        • Markus H.S.
        Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.
        Int J Stroke. 2011; 6: 47-59
        • Fisher C.M.
        The arterial lesions underlying lacunes.
        Acta Neuropathol. 1968; 12: 1-15
        • Grinberg L.T.
        • Thal D.R.
        Vascular pathology in the aged human brain.
        Acta Neuropathol. 2010; 119: 277-290
        • Lammie G.A.
        • Brannan F.
        • Slattery J.
        • Warlow C.
        Nonhypertensive cerebral small-vessel disease. An autopsy study.
        Stroke. 1997; 28: 2222-2229
        • Bailey E.L.
        • McCulloch J.
        • Sudlow C.
        • Wardlaw J.M.
        Potential animal models of lacunar stroke: a systematic review.
        Stroke. 2009; 40: e451-e458
        • Hainsworth A.H.
        • Markus H.S.
        Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review.
        J Cereb Blood Flow Metab. 2008; 28: 1877-1891
        • Schreiber S.
        • Bueche C.Z.
        • Garz C.
        • Kropf S.
        • Angenstein F.
        • Goldschmidt J.
        • Neumann J.
        • Heinze H.J.
        • Goertler M.
        • Reymann K.G.
        • Braun H.
        The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase?.
        J Cereb Blood Flow Metab. 2012; 32: 278-290
        • Michalski D.
        • Grosche J.
        • Pelz J.
        • Schneider D.
        • Weise C.
        • Bauer U.
        • et al.
        A novel quantification of blood–brain barrier damage and histochemical typing after embolic stroke in rats.
        Brain Res. 2010; 1359: 186-200
        • Okamoto K.
        • Yamori Y.
        • Nagaoka A.
        Establishment of the stroke-prone spontaneously hypertensive rat (SHR).
        Circ Res. 1974; 34 and 35: 143-153
        • De Reuck J.
        • Deramecourt V.
        • Cordonnier C.
        • Leys D.
        • Pasquier F.
        • Maurage C.A.
        Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study.
        J Neurol Sci. 2011; 300: 63-66
      1. Schreiber S, Bueche CZ, Garz C, Kropf S, Kuester D, Amann K et al. Kidney pathology precedes and predicts the pathological cascade of cerebrovascular lesions in stroke prone rats. PloS One 2011; in revision.

        • Thompson C.S.
        • Hakim A.M.
        Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis.
        Stroke. 2009; 40: e322-e330
        • Bogousslavsky J.
        • Regli F.
        • Maeder P.
        • Meuli R.
        • Nader J.
        The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography.
        Neurology. 1993; 43: 1528-1533
        • Min W.K.
        • Kim Y.S.
        • Kim J.Y.
        • Park S.P.
        • Suh C.K.
        Atherothrombotic cerebellar infarction: vascular lesion–MRI correlation of 31 cases.
        Stroke. 1999; 30: 2376-2381